Carvedilol increases copper-zinc superoxide dismutase activity in patients with acute myocardial infarction

Basic and Clinical Pharmacology and Toxicology

Volumn 101, Issue 2, 2007, Pages 138-142

  Kastratović, Dragana A ^a   Vasiljević, Zorana M ^a   Spasić, Mihajlo B ^b   Perunicić, Jovan P ^a   Matić, Mihajlo ^a   Blagojević, Dusko P ^b   Mijalković, Dejan N ^b   Antonijević, Nebojsa M ^a   Marković, Srdjan Z ^b   Gojković Bukarica, Ljiljana ^b   Stojiljkovic, Milos P ^c   Lasica, Ratko M ^a   Jones, David R ^b   Nikolić Kokić, Aleksandra L ^b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Actavis Trading Ltd   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; KARVILEKS; METOPROLOL; PRESOLOL; STREPTOKINASE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; MALE; MONOTHERAPY; PRIORITY JOURNAL; THERAPY EFFECT;

ADRENERGIC ANTAGONISTS; CARBAZOLES; DRUG THERAPY, COMBINATION; ERYTHROCYTES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPANOLAMINES; STREPTOKINASE; SUPEROXIDE DISMUTASE;

EID: 34447628893     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00094.x     Document Type: Article

References (41)

1. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol 2002 34 : 379 88.
2. Grieve DJ, Shah AM. Oxidative stress in heart failure. More than just damage. Eur Heart J 2003 24 : 2180 5.
3. Simović M, Spasić MB, Michelson AM. Free radicals in human myocardial reperfusion injury. Life Chem Rep 1995 12 : 227 70.
4. Dickens BF, Weglicki WB, Boehme PA, Mak TI. Antioxidant and lysosomotropic properties of acridine-propranolol: protection against oxidative endothelial cell injury. J Mol Cell Cardiol 2002 34 : 129 37.
5. Yue TL, Lysko PG, Barone FC, Gu JL, Ruffolo RR, Feuerstein GZ. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection. Ann N Y Acad Sci 1994 738 : 230 42.
6. Kawai K, Qin F, Shite J, Mao W, Fukuoka S, Liang CS. Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol 2004 287 : H1003 12.
7. Gomes A, Costa D, Lima CFLJ, Fernandes E. Antioxidant activity of B-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem 2006 14 : 4568 77.
8. Mavelli I, Ciriolo MR, Rotilio G. Multiple electrophoretic variants of Cu, Zn superoxide dismutase as expression of enzyme aging. Effects of H2O2, ascorbate and metal ions. Biochem Biophys Res Commun 1983 117 : 677 81.
9. Brunelli L, Yermilov V, Beckman JS. Modulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Radic Biol Med 2001 30 : 709 14.
10. Nikolić M, Vranić D, Spirić A et al. Could cholesterol bound to haemoglobin be 10 a missing link the occasional inverse relationship between superoxide dismutase and glutathione peroxidase activities? Biochem Biophys Res Commun 2006 348 : 265 70.
11. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 2006 59 : 527 605.
12. Gul M, Kutay FZ, Temocin S, Hanninen O. Cellular and clinical implications of glutathione. Indian J Exp Biol 2000 38 : 625 34.
13. Sinet PM, Michelson AM, Bazin A, Lejeune J, Jerome H. Increase in glutathione peroxidase activity in erythrocytes from Trisomy 21 subjects. Biochem Biophys Res Commun 1975 67 : 910 15.
14. Pastor MC, Sierra C, Dolade M et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down syndrome patients. Clin Chem 1998 44 : 924 9.
15. Ohlin H, Pavlidis N, Ohlin AK. Effects of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1998 82 : 1463 7.
16. European Parliament and the Council of the European Union. Directive 2001/20/EC of the European Parliament and of the Council on the approximation of the laws, regulations and administrative provisions of the Member States relating to implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. May 1, 2001 (http://www.eortc.be/ services/Doc/clinical-EU-directive-04-April-01.pdf) (accessed May 16, 2003).
17. Drabkin D, Austin H. Spectrophotometric studies. Preparations from washed blood cells. J Biol Chem 1935 112 : 51 5.
18. Tsuchihashi M. Zur Kenntnis der Blutkatalase. Biochem Z 1923 140 : 65 74.
19. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969 244 : 6049 55.
20. Beutler E, Catalase. A Manual of biochemical methods. In : Beutler E (ed.). Red Cell Metabolism. Grune and Stratton, New York, 1982 105 6.
21. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967 70 : 74 7.
22. Glatzle D, Vuilleumier JP, Weber F, Decker K. Glutathione reductase test with whole blood a convenient procedure for the assessment of the riboflavin status in humans. Experientia 1974 30 : 665 8.
23. Hinkle ED, Wiersma W, Jurs GS. Applied Statistics for Behavioral Sciences, 3rd ed, Houghton Mifflin Company, Boston, MA, 1994.
24. Manley BFJ. Multivariate Statistical Methods: A Primer. Chapman and Hall, London, 1986.
25. Blagojević D, Buzadzić B, Korac B et al. Seasonal changes in the antioxidant defense in ground squirrel (Citellus citellus): possible role of GSH-Px. J Environ Pathol Toxicol Oncol 1998 17 : 241 250.
26. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activity in human erythrocytes. Clin Chem 1997 43 : 562 8.
27. Nikolić-Kokić A, Stević Z, Blagojević D, Davidović D, Jones DR, Spasić MB. Alterations in anti-oxidative defence enzymes in erythrocytes from sporadic amyotrophic lateral sclerosis (SALS) and familial ALS patients. Clin Chem Lab Med 2006 44 : 589 93.
28. Rosanio S, Ye Y, Atar S et al. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther 2006 20 : 5 8.
29. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984 54 : 277 85.
30. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke 1996 27 : 761 5.
31. Tsao PS, Aoki N, Lefer DJ, Johnson G 3rd, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990 82 : 402 12.
32. Turrens JF, Beconi M, Barilla J, Chavez UB, McCord JM. Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues. Free Radic Res Commun 1991 12-13 : 681 9.
33. Bor MV, Cevik C, Uslu I, Guneral F, Duzgun E. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol 1999 54 : 271 6.
34. Muzáková V, Kand'ár R, Vojtíšek P et al. Antioxidant vitamin levels and glutathione peroxidase activity during ischemia/reperfusion in myocardial infarction. Physiol Res 2001 50 : 389 96.
35. Davidović B, Kastratović D, Nikolić A, Mijalković DN, Saničanin Z, Spasić MB. Antioxidative defense enzyme inhibition in erythrocytes of patients with acute myocardial infraction. Yugoslav Physiol Pharmacol Acta 2002 38 : 77 84.
36. Dusinović S, Mijalković D, Saičić ZS et al. Antioxidative defense in human myocardial reperfusion injury. J Environ Pathol Toxicol Oncol 1998 17 : 281 4.
37. Simić D, Mimić-Oka J, Pljesa M et al. Time course of erythrocyte antioxidant activity in patients treated by thrombolysis for acute myocardial infarction. Jpn Heart J 2003 44 : 823 32.
38. Djujić I, Jozanov-Stankov O, Demajo M. Oxidative stress and antioxidant defense markers in the population of Serbia and Montenegro. Yugoslav Physiol Pharmacol Acta 2003 39 : 121 8.
39. Nikolić M, Vranić D, Nikolić A et al. Does cholesterol bound to haemoglobin affect the anti-oxidant enzyme defence system in human erythrocytes? J Serb Chem Soc 2007 27 : 339 45.
40. Granville DJ, Tashakkor B, Takeuchi C et al. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci USA 2004 101 : 1321 6.
41. Arumanayagam M, Chan S, Tong S, Sanderson JE. Antioxidant properties of carvedilol and metoprolol in heart failure: A double-blind randomized controlled trial. J Cardiovasc Pharmacol 2001 37 : 48 54.